Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Journal of Gynecological Cancer

• Publication date

  2000-09-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1525-1438.2000.010005358.XPMID 11240699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy for advanced and/or recurrent cervical cancer

  2005cited by this paper
• Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  1999cited by this paper
• Chemotherapy in squamous cell carcinoma of the cervix uteri: present role and perspectives.

  1998cited by this paper
• Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

  1997cited by this paper
• Cancer of the uterine cervix.

  1996cited by this paper
• The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.

  1996cited by this paper
• Chemotherapy as a palliative treatment in carcinoma of the uterine cervix.

  1995cited by this paper
• The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review

  1991cited by this paper
• [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].

  1991cited by this paper
• A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix.

  1991cited by this paper
• Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.

  1989cited by this paper
• Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin

  1989cited by this paper
• Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.

  1987cited by this paper
• Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.

  1987cited by this paper
• Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.

  1985cited by this paper
• Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

  1985cited by this paper
• Chemotherapy of cervical carcinoma.

  1982cited by this paper
• Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix.

  1982cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum(II) (BOMP).

  1980cited by this paper
• The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.

  1972cited by this paper

• Management of Recurrent Uterine Cervical Cancer

  2019cites this paper
• Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.

  2016cites this paper
• EORTC Gynecological Cancer Group on the frontline of practice-changing clinical trials

  2012cites this paper
• Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.

  2006cites this paper
• The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.

  2004cites this paper
• Prognostic factors that predict survival after relapse of cervical cancer

  2001cites this paper
• Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.

  2001cites this paper